WallStreetZenWallStreetZen

NASDAQ: TPST
Tempest Therapeutics Inc Stock Ownership - Who owns Tempest Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tempest Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Versant Venture Capital VI LP10% Owner2024-08-12387,999$1.10
$427.19kSell
Versant Venture Capital VI LP10% Owner2024-08-08400,000$1.35
$540.00kSell
Stephen R. BradyPresident and CEO2024-07-0335,000$2.11
$73.85kBuy
Samuel WhitingChief Medical Officer2024-07-024,672$2.13
$9.95kBuy
Justin TrojanowskiCorporate Controller2024-06-287,500$2.16
$16.20kBuy

1 of 1

TPST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TPST insiders and whales buy or sell their stock.

TPST Shareholders

What type of owners hold Tempest Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michelle Dipp17.50%7,959,182$61.76MInsider
Richard Aldrich11.47%5,214,762$40.47MInsider
Christoph H. Westphal9.95%4,527,348$35.13MInsider
Versant Venture Capital VI LP7.71%3,507,056$27.21MInsider
Versant Venture Management LLC7.71%3,507,055$27.21MInstitution
Bessemer Venture Partners VII LP5.26%2,392,034$18.56MInsider
Thomas Woiwode4.80%2,183,788$16.95MInsider
Versant Vantage II LP4.66%2,118,644$16.44MInsider
Longwood Fund LP4.04%1,839,689$14.28MInsider
Mohamad Makhzoumi3.88%1,766,407$13.71MInsider

1 of 3

TPST vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TPST11.85%88.15%Net Selling
AUTL63.24%0.00%
HRTX49.06%50.94%
ARCT87.85%12.15%Net Selling
MAZE0.00%18.22%
View Top Biotech Stocks

Tempest Therapeutics Stock Ownership FAQ

Who owns Tempest Therapeutics?

Tempest Therapeutics (NASDAQ: TPST) is owned by 14.91% institutional shareholders, 110.96% Tempest Therapeutics insiders, and 0.00% retail investors. Michelle Dipp is the largest individual Tempest Therapeutics shareholder, owning 7.96M shares representing 17.50% of the company. Michelle Dipp's Tempest Therapeutics shares are currently valued at $61.76M.

If you're new to stock investing, here's how to buy Tempest Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.